95 related articles for article (PubMed ID: 23682021)
1. Mesenchymal stem cells in prostate cancer have higher expressions of SDF-1, CXCR4 and VEGF.
Ding G; Wang L; Xu H; Xu Z; Feng C; Ding Q; Fang Z; Wu Z; Jiang H; Xu J; Gao P
Gen Physiol Biophys; 2013 Jun; 32(2):245-50. PubMed ID: 23682021
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866
[TBL] [Abstract][Full Text] [Related]
3. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.
Luo J; Ok Lee S; Liang L; Huang CK; Li L; Wen S; Chang C
Oncogene; 2014 May; 33(21):2768-78. PubMed ID: 23792449
[TBL] [Abstract][Full Text] [Related]
4. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow mesenchymal stem cells promote the progression of prostate cancer through the SDF-1/CXCR4 axis in vivo and vitro.
Luo F; Su Y; Zhang Z; Li J
Clin Transl Oncol; 2022 May; 24(5):892-901. PubMed ID: 34855138
[TBL] [Abstract][Full Text] [Related]
6. CXCR4 and CXCL12 (SDF-1) in prostate cancer: inhibitory effects of human single chain Fv antibodies.
Vaday GG; Hua SB; Peehl DM; Pauling MH; Lin YH; Zhu L; Lawrence DM; Foda HD; Zucker S
Clin Cancer Res; 2004 Aug; 10(16):5630-9. PubMed ID: 15328206
[TBL] [Abstract][Full Text] [Related]
7. CXCR4 transfection of cord blood mesenchymal stromal cells with the use of cationic liposome enhances their migration toward stromal cell-derived factor-1.
Marquez-Curtis LA; Gul-Uludag H; Xu P; Chen J; Janowska-Wieczorek A
Cytotherapy; 2013 Jul; 15(7):840-9. PubMed ID: 23623275
[TBL] [Abstract][Full Text] [Related]
8. Regulation of VEGF, MMP-9 and metastasis by CXCR4 in a prostate cancer cell line.
Wang Q; Diao X; Sun J; Chen Z
Cell Biol Int; 2011 Sep; 35(9):897-904. PubMed ID: 21306303
[TBL] [Abstract][Full Text] [Related]
9. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
[TBL] [Abstract][Full Text] [Related]
10. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo.
Sun YX; Wang J; Shelburne CE; Lopatin DE; Chinnaiyan AM; Rubin MA; Pienta KJ; Taichman RS
J Cell Biochem; 2003 Jun; 89(3):462-73. PubMed ID: 12761880
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC
Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells overexpressing C-X-C chemokine receptor type 4 improve early liver regeneration of small-for-size liver grafts.
Du Z; Wei C; Yan J; Han B; Zhang M; Peng C; Liu Y
Liver Transpl; 2013 Feb; 19(2):215-25. PubMed ID: 23193024
[TBL] [Abstract][Full Text] [Related]
13. Cell surface engineering to enhance mesenchymal stem cell migration toward an SDF-1 gradient.
Won YW; Patel AN; Bull DA
Biomaterials; 2014 Jul; 35(21):5627-35. PubMed ID: 24731711
[TBL] [Abstract][Full Text] [Related]
14. The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation.
Bhakta S; Hong P; Koc O
Cardiovasc Revasc Med; 2006; 7(1):19-24. PubMed ID: 16513519
[TBL] [Abstract][Full Text] [Related]
15. [Effects of Snail gene modification on CXCR4 expression of human bone mesenchymal stem cells and their capacity of migration to SDF-1 in vitro].
Ni J; Liu X; Zha Y; Mei Y
Sheng Wu Gong Cheng Xue Bao; 2009 Feb; 25(2):242-50. PubMed ID: 19459330
[TBL] [Abstract][Full Text] [Related]
16. SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion.
Hong X; Jiang F; Kalkanis SN; Zhang ZG; Zhang XP; DeCarvalho AC; Katakowski M; Bobbitt K; Mikkelsen T; Chopp M
Cancer Lett; 2006 May; 236(1):39-45. PubMed ID: 15967572
[TBL] [Abstract][Full Text] [Related]
17. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
[TBL] [Abstract][Full Text] [Related]
18. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases.
Son BR; Marquez-Curtis LA; Kucia M; Wysoczynski M; Turner AR; Ratajczak J; Ratajczak MZ; Janowska-Wieczorek A
Stem Cells; 2006 May; 24(5):1254-64. PubMed ID: 16410389
[TBL] [Abstract][Full Text] [Related]
19. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model.
Kitaori T; Ito H; Schwarz EM; Tsutsumi R; Yoshitomi H; Oishi S; Nakano M; Fujii N; Nagasawa T; Nakamura T
Arthritis Rheum; 2009 Mar; 60(3):813-23. PubMed ID: 19248097
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
